XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (5,300) $ (18,591)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 885 671
Amortization of intangible assets 44 1,904
Stock-based compensation 1,668 4,242
Unrealized (gain) loss on marketable equity securities (97) 325
Amortization of debt issuance costs 11
Change in fair value of contingent consideration (16,512) (11,015)
Change in fair value of Series A redeemable convertible preferred stock second tranche obligation (305)
Impairment loss from intangible assets 4,950
Loss on disposal of discontinued operations 149
Loss on disposal and held for sale assets 1,283
Changes in operating assets and liabilities:    
Accounts receivable 296 (365)
Prepaid expenses and other assets 376 (773)
Accounts payable and accrued liabilities (4,319) 239
Accrued severance and liabilities from Chronix Biomedical acquisition (817)
Lease liabilities (118) (50)
Assets held for sale 191
Net cash used in operating activities (16,504) (24,524)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from sale of equipment 123
Construction in progress and purchases of furniture and equipment (2,679)
Net cash provided by (used in) investing activities 123 (2,679)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from sale of common shares 13,848 32,812
Financing costs to issue common shares (427) (389)
Proceeds from sale of redeemable convertible Series A preferred shares 4,875
Redemption of redeemable convertible Series A preferred shares (1,118)
Financing costs to issue redeemable convertible Series A preferred shares (93)
Proceeds from sale of common shares under at-the-market transactions 31
Financing costs for at-the-market sales (1)
Repayment of loan payable (750)
Repayment of financing lease obligations (57) (51)
Net cash provided by financing activities 12,246 36,434
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH (4,135) 9,231
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING 23,203 37,305
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, ENDING 19,068 46,536
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid for interest 21
SUPPLEMENTAL SCHEDULE OF NONCASH FINANCING AND INVESTING ACTIVITIES    
Construction in progress, machinery and equipment purchases included in accounts payable, accrued liabilities and landlord liability $ 16 $ 1,331